Meeting
2019 Supportive Care in Oncology Symposium
Feasibility of a collaborative palliative and oncology care intervention to improve symptoms and coping during head and neck chemoradiation.
Authors
Jessica Ruth Bauman
Fox Chase Cancer Center, Philadelphia, PA
Jessica Ruth Bauman, Jessie Panick, Thomas James Galloway, John A. Ridge, Melissa McShane, Marcin Chwistek, Molly Collins, Leigh Kinczewski, Kathleen Murphy, Marie Welsh, Matthew Farren, Mollie Clark, Jacqueline Kelly, Katherine Schuster, Lauren Stokes, Sheila Amrhein, Florence Bender, Brian L. Egleston, Areej El-Jawahri, Carolyn Y Fang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Advance Care Planning,End-of-Life Care,Communication and Shared Decision Making,Integration and Delivery of Palliative and Supportive Care,Coordination and Continuity of Care,Caregiver Support,Biology of Symptoms and Treatment Toxicities,Disparities in Supportive Care
Sub Track
Integration and Delivery of Palliative and Supportive Care
Clinical Trial Registration Number
NCT03760471
Citation
J Clin Oncol 37, 2019 (suppl 31; abstr 73)
DOI
10.1200/JCO.2019.37.31_suppl.73
Abstract #
73
Poster Bd #
G4
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Comparison of patient performance between PEG/no PEG placement in head and neck cancer patients during chemoradiotherapy treatment.
First Author: Robin Metcalfe-Klaw
Poster
2012 ASCO Annual Meeting
Clinical needs of patients referred early to supportive and palliative care.
First Author: Jung Hye Kwon
Poster
2023 ASCO Quality Care Symposium
Objective physical activity measures to predict hospitalizations among patients with cancer receiving chemoradiotherapy.
First Author: Anthony D. Scotina
Poster
2023 ASCO Annual Meeting
One-year reductions in cisplatin-related chronic kidney disease (CKD) in patients with head and neck (HNC) cancer treated with avasopasem manganese: A prespecified analysis from the phase 3 ROMAN trial.
First Author: Bryan G. Allen